Balasa Dinverno & Foltz’s Exelon EXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $727K | Sell |
19,398
-6,548
| -25% | -$290K | 0.05% | 165 |
|
|
2022
Q2 | $1.18M | Buy |
25,946
+6,806
| +36% | +$320K | 0.07% | 115 |
|
|
2022
Q1 | $912K | Sell |
19,140
-4,927
| -20% | -$209K | 0.06% | 138 |
|
|
2021
Q4 | $992K | Buy |
24,067
+3,690
| +18% | +$139K | 0.06% | 130 |
|
|
2021
Q3 | $703K | Buy |
20,377
+623
| +3% | +$21.3K | 0.05% | 157 |
|
|
2021
Q2 | $624K | Buy |
19,754
+729
| +4% | +$23.5K | 0.04% | 163 |
|
|
2021
Q1 | $594K | Buy |
19,025
+1,050
| +6% | +$31.5K | 0.05% | 168 |
|
|
2020
Q4 | $541K | Buy |
17,975
+2,941
| +20% | +$86.8K | 0.04% | 161 |
|
|
2020
Q3 | $383K | Buy |
15,034
+19
| +0.1% | +$504 | 0.04% | 183 |
|
|
2020
Q2 | $389K | Sell |
15,015
-19,591
| -57% | -$520K | 0.04% | 149 |
|
|
2020
Q1 | $909K | Sell |
34,606
-16,589
| -32% | -$522K | 0.11% | 89 |
|
|
2019
Q4 | $1.67M | Sell |
51,195
-2,038
| -4% | -$66K | 0.18% | 56 |
|
|
2019
Q3 | $1.83M | Sell |
53,233
-17,501
| -25% | -$588K | 0.21% | 49 |
|
|
2019
Q2 | $2.42M | Buy |
70,734
+11,672
| +20% | +$412K | 0.28% | 33 |
|
|
2019
Q1 | $2.11M | Buy |
59,062
+2,891
| +5% | +$98.4K | 0.25% | 36 |
|
|
2018
Q4 | $1.81M | Buy |
56,171
+3,459
| +7% | +$111K | 0.23% | 43 |
|
|
2018
Q3 | $1.64M | Buy |
52,712
+3,416
| +7% | +$105K | 0.18% | 48 |
|
|
2018
Q2 | $1.5M | Buy |
49,296
+1,942
| +4% | +$55.6K | 0.22% | 44 |
|
|
2018
Q1 | $1.32M | Buy |
47,354
+7,262
| +18% | +$196K | 0.2% | 48 |
|
|
2017
Q4 | $1.13M | Buy |
40,092
+837
| +2% | +$24.1K | 0.17% | 55 |
|
|
2017
Q3 | $1.05M | Buy |
39,255
+1,630
| +4% | +$43.6K | 0.16% | 55 |
|
|
2017
Q2 | $968K | Buy |
37,625
+3,805
| +11% | +$96.8K | 0.16% | 62 |
|
|
2017
Q1 | $868K | Sell |
33,820
-1,572
| -4% | -$40.1K | 0.15% | 62 |
|
|
2016
Q4 | $896K | Buy |
35,392
+5,743
| +19% | +$136K | 0.15% | 57 |
|
|
2016
Q3 | $704K | Buy |
29,649
+2,372
| +9% | +$59.6K | 0.13% | 69 |
|
|
2016
Q2 | $707K | Buy |
27,277
+10,641
| +64% | +$263K | 0.13% | 65 |
|
|
2016
Q1 | $426K | Buy |
16,636
+69
| +0.4% | +$1.55K | 0.08% | 102 |
|
|
2015
Q4 | $328K | Sell |
16,567
-944
| -5% | -$19.1K | 0.06% | 142 |
|
|
2015
Q3 | $371K | Sell |
17,511
-157
| -0.9% | -$3.53K | 0.07% | 115 |
|
|
2015
Q2 | $396K | Buy |
17,668
+1,245
| +8% | +$29.8K | 0.06% | 113 |
|
|
2015
Q1 | $394K | Buy |
16,423
+341
| +2% | +$8.45K | 0.06% | 108 |
|
|
2014
Q4 | $425K | Buy |
16,082
+682
| +4% | +$17.5K | 0.06% | 106 |
|
|
2014
Q3 | $374K | Sell |
15,400
-71
| -0.5% | -$1.66K | 0.06% | 107 |
|
|
2014
Q2 | $403K | Buy |
15,471
+482
| +3% | +$12.3K | 0.05% | 95 |
|
|
2014
Q1 | $359K | Sell |
14,989
-413
| -3% | -$8.69K | 0.04% | 98 |
|
|
2013
Q4 | $301K | Buy |
15,402
+1,270
| +9% | +$25.6K | 0.04% | 113 |
|
|
2013
Q3 | $299K | Buy |
14,132
+26
| +0.2% | +$569 | 0.05% | 101 |
|
|
2013
Q2 | $311K | Buy |
+14,106
| New | +$342K | 0.06% | 93 |
|
Other funds holding EXC
Balasa Dinverno & Foltz's EXC Position: Q3 2022 in Review
Balasa Dinverno & Foltz reduced its Exelon (EXC) stake by 25% in Q3 2022, selling an estimated $290K and leaving 19,398 shares worth $727K. The position accounts for 0.05% of the portfolio, ranked #165.
Balasa Dinverno & Foltz first reported a position in EXC in Q2 2013 and has held it in 38 quarters since. The position peaked at $2.42M in Q2 2019. 988 funds tracked by Wall St. Rank hold EXC as of Q3 2022.
- Balasa Dinverno & Foltz held 19,398 shares of Exelon worth $727K as of Q3 2022.
- Balasa Dinverno & Foltz sold 6,548 Exelon shares in Q3 2022, an estimated $290K.
- Exelon made up 0.05% of Balasa Dinverno & Foltz's portfolio in Q3 2022, its #165 holding.
- Balasa Dinverno & Foltz first reported a position in Exelon in Q2 2013 and has held it in 38 quarters since.
- Balasa Dinverno & Foltz's Exelon position peaked at $2.42M in Q2 2019.
- 988 funds tracked by Wall St. Rank held Exelon as of Q3 2022.
Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.